Home > Healthcare > Medical Devices > Therapeutic Devices > Non-energy Based Aesthetic Devices Market

Non-energy Based Aesthetic Devices Market Trends

Report ID: GMI6130
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Non-energy Based Aesthetic Devices Market Trends

Increasing demand for minimally invasive or non-invasive procedures to enhance physical appearance will offer momentous opportunity to market growth. Growing prevalence of obesity, congenital face deformities, high awareness among people regarding non-energy based aesthetic procedures as well as prevalence of ageing and dull skin among the geriatric population base will augment the demand for minimally invasive aesthetic procedures. As per estimates, the total number of aesthetic procedures performed in the U.S., in 2022, accounted for around 4.7 million, of which 3.1 million procedures were non-surgical. Developments in market to offer minimally invasive procedures coupled with advancement in healthcare facilities will further boost the market size.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Non-energy based aesthetic devices industry was worth USD 12.7 billion in 2022 and is estimated to reach USD 36.6 billion by 2032 driven by the increasing improvements in aesthetic appearances

The dermal filler product segment recorded USD 3.2 billion in 2022 and is poised to witness steady growth through 2032 attributed to the booming medical tourism sector, especially for cosmetic procedures.

U.S. non-energy based aesthetic devices market generated USD 6.1 billion in 2022 and is expected to grow at a robust pace through 2032 attributed to the rising affordability of aesthetic procedures among the target population base and the ongoing technological developments.

Some key non-energy based aesthetic devices providers include Merz Pharma GmbH & Co.KGaA, Allergan, Galderma, Sinclair Pharma, Cynosure, Syneron Candela, Prollenium Medical Technologies, Anika Therapeutics, Johnson & Johnson, and Ipsen